MedPath

The role of milk protein and other dried milk products in the growth and development of stunted childre

Not Applicable
Completed
Conditions
Stunting
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN13093195
Lead Sponsor
niversity of Copenhagen
Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34027295/ (added 13/08/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37220111/ results (added 24/05/2023) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38135004/ Analysis of plasma citrulline levels and correlations (added 27/12/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/38278366/ Secondary analysis (added 29/01/2024) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/39111553/ Correlates of body composition using baseline measurements data (added 09/08/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
750
Inclusion Criteria

1. Age 12 - 59 months
2. Height-age-Z < -2 according to WHO growth standards (2006)
3. Care-taker able and willing to return for follow-up visits and agrees to phone follow-up
4. Living within the catchment area
5. Written informed consent given by parent/caregiver

Exclusion Criteria

1. Severe acute malnutrition, defined as MUAC <115 mm OR WHZ<-3 OR bilateral pitting oedema
2. Medical complications requiring hospitalization
3. Obvious disability that impedes eating capacity
4. Disability that makes length/height assessment problematic
5. Participation in another study which impacts on this study or previous enrollment in this study
6. Family plans to move away from the catchment area in the next 6 months
7. History or known allergy to peanuts or milk

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measured at baseline and 12-weeks:<br>1. Knee-heel length (mm)<br>2. Height (cm)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath